These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9634988)

  • 21. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
    Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome.
    Humphreys-Beher MG; Hu Y; Nakagawa Y; Wang PL; Purushotham KR
    Adv Exp Med Biol; 1994; 350():631-6. PubMed ID: 8030546
    [No Abstract]   [Full Text] [Related]  

  • 23. Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse.
    Gilbard JP; Hanninen LA; Rothman RC; Kenyon KR
    Curr Eye Res; 1987 Oct; 6(10):1237-48. PubMed ID: 3677784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Innervation of the lachrymal gland in patients with primary Sjögren's syndrome. An immunohistopathological study].
    Rivas L; Murube J; Toledano A
    Arch Soc Esp Oftalmol; 2002 Nov; 77(11):623-29. PubMed ID: 12410409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model.
    Tsubota K; Saito I; Ishimaru N; Hayashi Y
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1551-9. PubMed ID: 9699544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models.
    Hawley D; Tang X; Zyrianova T; Shah M; Janga S; Letourneau A; Schicht M; Paulsen F; Hamm-Alvarez S; Makarenkova HP; Zoukhri D
    Sci Rep; 2018 Jul; 8(1):9919. PubMed ID: 29967327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ultrastructural study of the lacrimal gland in Gougerot-Sjögren syndrome].
    Chomette G; Liotet S; Auriol M; Bellefqih S; Laroche L
    Arch Anat Cytol Pathol; 1985; 33(3):149-54. PubMed ID: 4037878
    [No Abstract]   [Full Text] [Related]  

  • 29. Diffusion-weighted MR microimaging of the lacrimal glands in patients with Sjogren's syndrome.
    Kawai Y; Sumi M; Kitamori H; Takagi Y; Nakamura T
    AJR Am J Roentgenol; 2005 Apr; 184(4):1320-5. PubMed ID: 15788618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of lacrimal gland function, apoptotic figures, Fas and Fas ligand expression of lacrimal glands in dry eye patients.
    Tsubota K; Fujita H; Tsuzaka K; Takeuchi T
    Exp Eye Res; 2003 Feb; 76(2):233-40. PubMed ID: 12565811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
    Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histology of the lacrimal gland in keratoconjunctivitis sicca.
    Williamson J; Gibson AA; Wilson T; Forrester JV; Whaley K; Dick WC
    Br J Ophthalmol; 1973 Nov; 57(11):852-8. PubMed ID: 4785251
    [No Abstract]   [Full Text] [Related]  

  • 34. The clinical value and histopathological correlation of lacrimal scintigraphy in patients with primary Sjögren's syndrome.
    Erhamamci S; Karalezli A; Yilmaz S; Aktas A
    Nucl Med Commun; 2012 Jul; 33(7):689-94. PubMed ID: 22513885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjögren's syndrome.
    Kessler HS; Cubberly M; Manski W
    Arch Ophthalmol; 1971 Feb; 85(2):211-9. PubMed ID: 5545721
    [No Abstract]   [Full Text] [Related]  

  • 36. [Apoptosis and related gene expression in lacrimal gland of cases with Sjögren's syndrome].
    Wu J; Fei P; Gong Y; Zhao J; Dong J; Tang F
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):255-8, 14. PubMed ID: 11853607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gougerot-Sjogren syndrome].
    Brégeat P; Hamard H; Mondon H
    Annee Ther Clin Ophtalmol; 1971; 22():165-76. PubMed ID: 5163253
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electron microscopic findings and cellular immunity of the lacrimal gland in Sjogren's disease].
    Sarata K; Matsuo N; Hasegawa E; Miyagawa K; Kamoi S
    Nihon Rinsho; 1983; 41(2):442-4. PubMed ID: 6865013
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2
    Kiripolsky J; Shen L; Liang Y; Li A; Suresh L; Lian Y; Li QZ; Gaile DP; Kramer JM
    Clin Immunol; 2017 Oct; 183():225-232. PubMed ID: 28526333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.